Quick search
Advanced search in
Field to searchTerm
Add rule
Download Results
5 research outcomes, page 1 of 1
  • publication . Article . 2015
    Open Access Russian
    Persistent Identifiers
    Publisher: LLC "Diagnostics and Vaccines"

    The article presents the results of studies of the effectiveness and safety of domestic antiviral drug Аrbidol in children. Arbidol demonstrated antiviral activity not only against influenza viruses, and other respiratory viruses (respiratory syncytial virus, parainflue...

    Add to ORCID
  • publication . Article . 2020
    Open Access Russian
    Authors:
    L. N. Mazankova; I. M. Osmanov; E. R. Samitova; A. A. Nedostoev; S. O. Kotenko; O. S. Kulichkina;
    Persistent Identifiers
    Publisher: LLC "Diagnostics and Vaccines"

    A new coronavirus infectionin children in most cases is easier than in adult patients, however, some cases are characterized by a protracted course and duration of the release of SARS-CoV-2 virus.The article presents own data monitoring of children with novel coronaviru...

    Add to ORCID
  • publication . Article . 2018
    Open Access
    Authors:
    L. V. Poslova; O. V. Kovalishena; A. V. Sergeeva; D. V. Kvashnina;
    Persistent Identifiers
    Publisher: Journal of Childrens Infections

    The results of the evaluation of the incidence of acute respiratory viral infection (ARVI) in a large children's multidisciplinary hospital are presented.It was established that the epidemic process of ARVI in the conditions of a children's versatile hospital was charac...

    Add to ORCID
  • publication . Article . Other literature type . 2020
    Open Access
    Persistent Identifiers
    Publisher: Journal of Childrens Infections

    30 января 2020 года Всемирная Организация Здравоохранения (ВОЗ) признала вспышку коронавирусной инфекции в Китае чрезвычайной ситуацией в области общественного здравоохранения, имеющую международное значение. Генеральный директор ВОЗ Тедрос Адханом Гебрейесус после сове...

    Add to ORCID
  • publication . Article . 2017
    Open Access
    Persistent Identifiers
    Publisher: Journal of Childrens Infections

    A new value was acquired by the drug Orvirem®, which is a combination of rimantadine and natrium alginate. In recent years, it has not been recommended for use due to the resistance to it strains of the influenza A(H1N1) virus pdm2009. Currently, this drug has acquired ...

    Add to ORCID
5 research outcomes, page 1 of 1